Global Commercial Roadmap For An Asset Case Study

Global Commercial Roadmap Asset Case Study Objective:

To develop a comprehensive commercial roadmap for the life of an asset, including key activities and their timing, ownership and budget constraints.

Methodology:

  • Reviewed and benchmarked all commercial activities by stage of an asset

  • Identified best practices by size of the company as well as therapeutic area

  • Interviewed key stakeholders on global and affiliate roles to understand pain points and potential best practices

  • Aligned activities by stage gate and built in key transition points across global and affiliate teams

  • Conducted workshops to socialize details of commercial roadmap

Value Added:

  • Comprehensive commercial roadmap for the life of an asset, including list of global and affiliate roles and responsibilities

  • Conducted pilot workshops to align affiliate teams

  • Integrated launch excellence framework with commercial roadmap

Latest Blogs

The FDA approved Dupixent for moderate-to-severe atopic dermatitis

April 14, 2017
  The FDA approved Dupixent On March 28th, the FDA approved Dupixent for moderate-to-severe atopic ...
Read more

Why Drug Pricing is in the News Now and What Can Be Done About It?

March 3, 2017
Why drug pricing is in the news now and what can be done about it? From Turing Pharmaceuticals to Mylan,...
Read more

Key Challenges Facing Obamacare Repeal and Replace Plan

February 3, 2017
ACA repeal and replacement complicated by two key challenges...
Read more

How Pharma Can Prepare for the Patent Cliff

February 2, 2017
Extending market exclusivity and responding properly to the volume of recent patent expiries are critica...
Read more